Republic Drug
This article was originally published in The Tan Sheet
Executive Summary
Plans to begin shipping a low-dose aspirin product in June to private-label customers. The company also will market the aspirin product under its Pharmacist's Choice control brand. In July, the firm expects to launch an antioxidant product and, in August, a lice shampoo formula (.33% pyrethrins) to compliment its .30% formula. New cough syrups are slated for autumn launch. During the spring, the company introduced Dormarex Sleep Capsules (25 mg diphenhydramine), reformulated Aqua Vac water tablets, and Triple A with pain killer (lidocaine 40 mg)
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning